BioCentury
ARTICLE | Company News

Madera BioSciences, Alzheimer's Drug Discovery Foundation (ADDF) neurology news

June 24, 2013 7:00 AM UTC

ADDF granted Madera $298,500 in follow-on funding to further develop its small molecule compounds that facilitate the release of apolipoprotein E (APOE), which may aid the beta amyloid clearance proce...